An innovative gene-editing strategy could establish a new way for the body to manufacture therapeutic proteins—including ...
Gene‑edited HPSCs programmed to make therapeutic antibodies and proteins show long‑lasting, boostable immunity in mouse models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results